Exelixis Inc Increase (Decrease) in Other Operating Liabilities
Exelixis Inc (EXEL) reported Increase (Decrease) in Other Operating Liabilities of $15.94 million for the 9-month period ending 2019-09-27, per its 10-Q filed 2019-10-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2019-10-30
- Exelixis Inc increase (decrease) in other operating liabilities for the quarter ending 2019-09-27 was $8.23M.
- Exelixis Inc increase (decrease) in other operating liabilities for the quarter ending 2019-06-28 was -$13.46M, a 244.44% decline year-over-year.
- Exelixis Inc increase (decrease) in other operating liabilities for the quarter ending 2019-03-29 was $21.17M.
- Exelixis Inc increase (decrease) in other operating liabilities for the quarter ending 2018-12-28 was $5.55M.
- Exelixis Inc increase (decrease) in other operating liabilities for fiscal 2018 was $2.23M.
- Exelixis Inc increase (decrease) in other operating liabilities for fiscal 2017 was -$9.17M, a 235.41% decline from fiscal 2016.
- Exelixis Inc increase (decrease) in other operating liabilities for fiscal 2016 was $6.77M.
- Exelixis Inc increase (decrease) in other operating liabilities for fiscal 2016 was $1.22M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-09-27 | $8.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$5.23M derived: sum of 2 quarters · filed 2019-10-30 | $15.94M 10-Q · filed 2019-10-30 | $21.49M derived: sum of 4 quarters · filed 2019-10-30 | ||||
| 2019-06-28 | -$13.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $7.71M 10-Q · filed 2019-07-31 | $13.26M derived: sum of 3 quarters · filed 2019-07-31 | $3.47M derived: sum of 4 quarters · filed 2019-10-30 | ||||
| 2019-03-29 | $21.17M 10-Q · filed 2019-05-01 | $26.72M derived: sum of 2 quarters · filed 2019-05-01 | $16.93M derived: sum of 3 quarters · filed 2019-10-30 | $26.25M derived: sum of 4 quarters · filed 2019-10-30 | ||||
| 2018-12-28 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$4.24M derived: sum of 2 quarters · filed 2019-10-30 | $5.08M derived: sum of 3 quarters · filed 2019-10-30 | $2.23M 10-K · filed 2019-02-22 | ||||
| 2018-09-28 | -$9.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$465.00K derived: sum of 2 quarters · filed 2019-10-30 | -$3.32M 10-Q · filed 2019-10-30 | -$22.97M derived: sum of 4 quarters · filed 2019-10-30 | ||||
| 2018-06-29 | $9.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $6.46M 10-Q · filed 2019-07-31 | $10.16M 10-Q · filed 2018-08-01 | -$13.19M derived: sum of 3 quarters · filed 2019-07-31 | -$8.44M derived: sum of 4 quarters · filed 2019-07-31 | |||
| 2018-03-30 | -$2.86M 10-Q · filed 2019-05-01 | $1.53M 10-Q · filed 2018-05-02 | -$22.50M derived: sum of 2 quarters · filed 2019-05-01 | -$17.76M derived: sum of 3 quarters · filed 2019-05-01 | ||||
| 2017-12-29 | -$19.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$14.91M derived: sum of 2 quarters · filed 2019-02-22 | -$9.17M 10-K · filed 2019-02-22 | $9.91M 10-K · filed 2018-02-26 | ||||
| 2017-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $12.20M 10-Q · filed 2017-11-01 | ||||||
| 2017-09-29 | $3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$450.00K derived: sum of 2 quarters · filed 2018-11-01 | $10.48M 10-Q · filed 2018-11-01 | $10.07M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | -$3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $7.46M 10-Q · filed 2017-08-02 | $7.05M derived: sum of 3 quarters · filed 2018-05-02 | $7.88M derived: sum of 4 quarters · filed 2018-05-02 | ||||
| 2017-03-31 | $10.93M 10-Q · filed 2017-05-01 | $10.52M derived: sum of 2 quarters · filed 2018-05-02 | $11.35M derived: sum of 3 quarters · filed 2018-05-02 | $15.33M derived: sum of 4 quarters · filed 2018-05-02 | ||||
| 2016-12-31 | -$409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $428.00K derived: sum of 2 quarters · filed 2017-11-01 | $4.41M derived: sum of 3 quarters · filed 2017-11-01 | $6.77M 10-K · filed 2017-02-27 | ||||
| 2016-12-30 | $1.22M 10-K · filed 2019-02-22 | $5.09M 10-K · filed 2018-02-26 | ||||||
| 2016-09-30 | $837.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $4.82M derived: sum of 2 quarters · filed 2017-11-01 | $7.18M 10-Q · filed 2017-11-01 | -$815.00K 10-Q · filed 2016-11-03 | -$1.85M derived: sum of 4 quarters · filed 2017-11-01 | |||
| 2016-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $6.35M 10-Q · filed 2017-08-02 | -$493.00K 10-Q · filed 2016-08-03 | -$2.68M derived: sum of 3 quarters · filed 2017-08-02 | -$3.15M derived: sum of 4 quarters · filed 2017-08-02 | |||
| 2016-03-31 | $2.37M 10-Q · filed 2017-05-01 | -$258.00K 10-Q · filed 2016-05-04 | -$6.66M derived: sum of 2 quarters · filed 2017-05-01 | -$7.13M derived: sum of 3 quarters · filed 2017-05-01 | -$7.74M derived: sum of 4 quarters · filed 2017-05-01 | |||
| 2016-01-01 | -$10.50M 10-K · filed 2018-02-26 | |||||||
| 2015-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$9.49M derived: sum of 2 quarters · filed 2017-02-27 | -$10.11M derived: sum of 3 quarters · filed 2017-02-27 | -$10.40M 10-K · filed 2017-02-27 | -$1.67M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | -$464.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.08M derived: sum of 2 quarters · filed 2016-11-03 | -$1.37M 10-Q · filed 2016-11-03 | -$5.91M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$903.00K 10-Q · filed 2016-08-03 | -$5.44M derived: sum of 3 quarters · filed 2017-02-27 | -$5.72M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | -$288.00K 10-Q · filed 2016-05-04 | -$4.83M derived: sum of 2 quarters · filed 2017-02-27 | -$5.10M derived: sum of 3 quarters · filed 2017-02-27 | -$5.35M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | -$4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$4.82M derived: sum of 2 quarters · filed 2017-02-27 | -$5.07M derived: sum of 3 quarters · filed 2017-02-27 | -$5.29M 10-K · filed 2017-02-27 | -$1.43M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | -$277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$527.00K derived: sum of 2 quarters · filed 2015-11-10 | -$756.00K 10-Q · filed 2015-11-10 | -$1.92M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$479.00K 10-Q · filed 2015-08-11 | -$1.64M derived: sum of 3 quarters · filed 2016-02-29 | -$1.79M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$229.00K 10-Q · filed 2015-04-30 | -$1.39M derived: sum of 2 quarters · filed 2016-02-29 | -$1.54M derived: sum of 3 quarters · filed 2016-02-29 | -$1.78M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$1.32M derived: sum of 2 quarters · filed 2016-02-29 | -$1.55M derived: sum of 3 quarters · filed 2016-02-29 | -$1.69M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$387.00K derived: sum of 2 quarters · filed 2014-11-04 | -$530.00K 10-Q · filed 2014-11-04 | -$2.04M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$374.00K 10-Q · filed 2014-07-31 | -$1.89M derived: sum of 3 quarters · filed 2015-03-02 | -$1.68M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | -$143.00K 10-Q · filed 2014-05-01 | -$1.66M derived: sum of 2 quarters · filed 2015-03-02 | -$1.45M derived: sum of 3 quarters · filed 2015-03-02 | -$1.64M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$1.30M derived: sum of 2 quarters · filed 2015-03-02 | -$1.50M derived: sum of 3 quarters · filed 2015-03-02 | -$1.59M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $11.00K derived: sum of 2 quarters · filed 2013-10-30 | -$76.00K 10-Q · filed 2013-10-30 | -$480.00K derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-06-30 | -$199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$286.00K 10-Q · filed 2013-08-06 | -$690.00K derived: sum of 3 quarters · filed 2014-02-20 | -$888.00K derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-03-31 | -$87.00K 10-Q · filed 2013-05-07 | -$491.00K derived: sum of 2 quarters · filed 2014-02-20 | -$689.00K derived: sum of 3 quarters · filed 2014-02-20 | -$1.02M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2011-12-31 | -$404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$602.00K derived: sum of 2 quarters · filed 2014-02-20 | -$930.00K derived: sum of 3 quarters · filed 2014-02-20 | -$1.16M 10-K · filed 2014-02-20 | ||||
| 2011-09-30 | -$198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$526.00K derived: sum of 2 quarters · filed 2012-11-07 | -$758.00K 10-Q · filed 2012-11-07 | -$7.82M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | -$328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$560.00K 10-Q · filed 2012-08-02 | -$7.62M derived: sum of 3 quarters · filed 2013-02-21 | -$7.85M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | -$232.00K 10-Q · filed 2012-05-03 | -$7.30M derived: sum of 2 quarters · filed 2013-02-21 | -$7.52M derived: sum of 3 quarters · filed 2013-02-21 | |||||
| 2010-12-31 | -$7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$7.29M derived: sum of 2 quarters · filed 2013-02-21 | -$8.32M 10-K · filed 2013-02-21 | |||||
| 2010-09-30 | -$227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$1.26M 10-Q · filed 2011-10-27 | ||||||
| 2010-06-30 | -$1.03M 10-Q · filed 2011-08-04 | |||||||
| 2009-12-31 | -$5.29M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |